Fundraising Fox

Goldenrod Therapeutics, Inc.

Houston, US · Founded 2023 · Texas corporation · 1 known investors

Biotech

Founders & leadership

DC
Dev ChatterjeeExecutive Officer
LL
Leo Linbeck IVExecutive Officer
MW
Mark WorschehExecutive Officer, Director
AV
Atul VaradhacharyExecutive Officer, Director
LL
Leo Linbeck IIIDirector
TB
Thomas BrenninkmeijerDirector

Investors · 1

Fannin Goldenrod HoldingsreportedHouston

Reported raises · per SEC filings

Form D private placements
▶$3.2MraisedJun 2026 · 2 investors · Biotechnology
Rule 506(b)
Goldenrod Therapeutics raises $6.5 million to test UNMC-created drug that could change modern medicine - Silicon Prairie Newssiliconprairienews.com · Jul 2026Goldenrod Therapeutics, Fannin Partners secures $6.5M for FA drug study - InnovationMaphouston.innovationmap.com · Jun 2026
Officers, directors & promoters on the filing
  • Dev ChatterjeeExecutive Officer
  • Leo Linbeck IVExecutive Officer
  • Mark WorschehExecutive Officer, Director
  • Atul VaradhacharyExecutive Officer, Director
  • Leo Linbeck IIIDirector
  • Thomas BrenninkmeijerDirector
Offering amount
$6.5M
Amount sold
$3.2M
Minimum investment
$100K
First sale
May 2026
Incorporated
Corporation, Texas, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news